A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation
Clinical trial NCT05379829 · COMPLETED
Trial details
- NCT number
- NCT05379829
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2024-06-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.